Your browser is no longer supported. Please, upgrade your browser.
NVAX Novavax, Inc. daily Stock Chart
Novavax, Inc.
Index- P/E- EPS (ttm)-7.12 Insider Own0.10% Shs Outstand33.04M Perf Week6.32%
Market Cap269.77M Forward P/E- EPS next Y-3.08 Insider Trans-39.44% Shs Float31.92M Perf Month6.59%
Income-150.20M PEG- EPS next Q-1.06 Inst Own21.40% Short Float18.31% Perf Quarter121.27%
Sales16.00M P/S16.86 EPS this Y20.40% Inst Trans-4.64% Short Ratio1.37 Perf Half Y23.15%
Book/sh-7.80 P/B- EPS next Y44.40% ROA-76.70% Target Price13.75 Perf Year-78.74%
Cash/sh2.15 P/C3.79 EPS next 5Y0.00% ROE86.60% 52W Range3.54 - 43.40 Perf YTD105.15%
Dividend- P/FCF- EPS past 5Y-10.30% ROI- 52W High-82.00% Beta1.94
Dividend %- Quick Ratio4.10 Sales past 5Y10.40% Gross Margin- 52W Low120.64% ATR0.82
Employees379 Current Ratio4.10 Sales Q/Q-67.50% Oper. Margin- RSI (14)57.83 Volatility5.71% 9.13%
OptionableYes Debt/Eq- EPS Q/Q68.20% Profit Margin- Rel Volume0.70 Prev Close8.16
ShortableYes LT Debt/Eq- EarningsMar 16 AMC Payout- Avg Volume4.26M Price7.81
Recom2.30 SMA205.66% SMA5034.95% SMA20045.79% Volume2,160,771 Change-4.34%
Nov-27-19Resumed B. Riley FBR Buy $12
Aug-14-19Reiterated H.C. Wainwright Buy $10 → $17
Feb-28-19Downgrade Piper Jaffray Overweight → Underweight $4.50 → $0.25
Dec-18-18Initiated Ladenburg Thalmann Buy $3
Dec-11-18Initiated Oppenheimer Outperform $4
Nov-26-18Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18Upgrade JP Morgan Underweight → Overweight
Mar-29-18Upgrade Seaport Global Securities Neutral → Buy $5
Mar-19-18Downgrade JP Morgan Neutral → Underweight
Mar-01-18Upgrade Citigroup Neutral → Buy
Jan-05-18Initiated B. Riley FBR, Inc. Buy $2.25
Dec-19-17Downgrade Citigroup Buy → Neutral
Oct-31-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Feb-21-20 05:55AM  These are the steps needed for a vaccine to be approved MarketWatch
Feb-19-20 05:45PM  Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-14-20 11:30AM  Has Novavax (NVAX) Outpaced Other Medical Stocks This Year? Zacks
Feb-12-20 05:45PM  Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know Zacks
Feb-06-20 05:50PM  Can Biotech ETFs Continue to Soar in 2020? Zacks
Feb-05-20 06:53PM  Drugmakers see long road ahead in coronavirus vaccine race Reuters Videos
05:45PM  Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
03:19PM  FOCUS-Drugmakers see long road ahead in coronavirus vaccine race Reuters
Feb-04-20 11:11AM  Health Stocks Riding High on Virus Claims Draw Short Sellers Bloomberg
Feb-03-20 09:15AM  Novavax, Inc. (NVAX) Shares March Higher, Can It Continue? Zacks -10.63%
Jan-31-20 10:52AM  Some Drugmakers Are Racing to Develop a Coronavirus Vaccine. Why Big Pharma Isnt Rushing In. +8.86%
Jan-30-20 12:36PM  Coronavirus: How Fast to 100,000 Infected? Zacks
Jan-29-20 04:11PM  Coronavirus: Epidemic or Pandemic? Zacks
11:30AM  Has Novavax (NVAX) Outpaced Other Medical Stocks This Year? Zacks
Jan-28-20 02:23PM  Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports MarketWatch -15.65%
12:02PM  Will Coronavirus Propel This Vaccine Makers Stock Even Higher? TipRanks
Jan-27-20 04:42PM  3 Biotech Stocks Are Soaring Because Everyone Wants a Coronavirus Vaccine +8.97%
02:21PM  CDC officials say coronavirus is similar to SARS, no new U.S. cases reported MarketWatch
10:58AM  Analyst: China's coronavirus victims 'probably 10 times' higher than reported Yahoo Finance
08:43AM  Vaccine, diagnostics stocks rise again on spreading coronavirus MarketWatch
06:02AM  RPT-With Wuhan virus genetic code in hand, scientists begin work on a vaccine Reuters
Jan-24-20 04:46PM  With Wuhan virus genetic code in hand, scientists begin work on a vaccine Reuters
04:03PM  Novavax exec: Making a coronavirus vaccine could take a long time Yahoo Finance
03:08PM  Biotech ETFs Are Not Riding the Wave from Coronavirus Panic ETF Trends
09:20AM  Coronavirus-Linked Stock Speculation Reminds Health Sector of Bitcoin Bloomberg
08:55AM  CEPI Grant, Government Aid Drive Coronavirus Focused Biotechs Zacks
01:00AM  PRESS DIGEST -Wall Street Journal - Jan 24 Reuters
Jan-23-20 03:14PM  The latest coronavirus stock screamers: Inovio Pharmaceuticals, Co-Diagnostics MarketWatch +8.04%
01:02PM  13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
11:01AM  UPDATE: Vaccine stocks rise sharply as coronavirus fears mounts MarketWatch
10:18AM  3 Biotech Stocks Likely to Gain as Coronavirus Spreads Zacks
09:51AM  The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech Zacks
09:31AM  A Tale of 3 Healthcare Stocks 2 to Buy, and 1 to Sell TipRanks
06:54AM  Outbreak Sparks Biotech Booms But Vaccine Funding Is Missing Bloomberg
06:54AM  Vaccine makers tap into virus-driven rally to raise money MarketWatch
Jan-22-20 01:29PM  Coronavirus Stocks To Buy Zacks -27.80%
10:11AM  Company News for Jan 22, 2020 Zacks
08:51AM  Options Traders Expect Huge Moves in Novavax (NVAX) Stock Zacks
08:46AM  Novavax stock falls after jumping on virus concerns MarketWatch
08:25AM  The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings Benzinga
08:12AM  Coronavirus Infects Wall Street: Stocks to Gain & Lose Zacks
Jan-21-20 03:18PM  Novavax Is Working On A Wuhan Coronavirus Vaccine Candidate As First US Case Emerges Benzinga +71.08%
02:40PM  Experimental vaccine stocks jump on concerns about new virus in China MarketWatch
08:56AM  Benzinga Pro's Top 5 Stocks To Watch For Tues., Jan. 21, 2020: HAL, LB, NVAX, CAT, TCOM Benzinga
08:44AM  Novavax shares jump 60% in premarket trading MarketWatch
Jan-17-20 05:00AM  Share madness: These are the best and worst stock performers of 2019 American City Business Journals +20.08%
Jan-16-20 09:52AM  Novavax Rises on Fast Track Designation to Influenza Vaccine Zacks +9.13%
Jan-15-20 02:37PM  Novavax earns key FDA status for its flu vaccine. Wall Street took it well. American City Business Journals +9.77%
11:11AM  Is Novavax (NVAX) Stock on the Mend? Wall Street Pro Weighs In TipRanks
09:17AM  Benzinga Pro's Top 5 Stocks To Watch For Wed., Jan. 15, 2020: GS, RSX, NKTR, NVAX, ACB Benzinga
08:38AM  Novavax shares soar 20% premarket after company wins FDA fast-track designation for flu vaccine MarketWatch
08:30AM  Novavax Granted Fast Track Designation for NanoFlu in Older Adults GlobeNewswire
Jan-09-20 04:05PM  Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire -6.31%
Jan-07-20 10:53AM  Should You Worry About Novavax, Inc.'s (NASDAQ:NVAX) CEO Pay Cheque? Simply Wall St.
Dec-24-19 11:19AM  Should You Buy Novavax, Inc. (NVAX)? Insider Monkey
Dec-12-19 04:11PM  3 Biotech Stocks That Offer the Highest Upside on Wall Street TipRanks
Dec-02-19 08:51AM  Options Traders Expect Huge Moves in Novavax (NVAX) Stock Zacks +7.63%
Nov-27-19 06:26PM  This Vaccine Maker Could Skyrocket 200% in the Next 12 Months, Says Analyst TipRanks +5.07%
09:45AM  5 Strong Buy Biotech Stocks With More Than 80% Upside InvestorPlace
Nov-17-19 12:06AM  Edited Transcript of NVAX earnings conference call or presentation 7-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-08-19 03:04PM  Why 2020 could be a make-or-break year for Novavax American City Business Journals
01:36PM  One Thing To Remember About The Novavax, Inc. (NASDAQ:NVAX) Share Price Simply Wall St.
Nov-07-19 04:05PM  Novavax Reports Third Quarter 2019 Financial Results GlobeNewswire
Oct-31-19 04:05PM  Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019 GlobeNewswire -5.66%
Oct-30-19 10:33AM  Will Novavax (NVAX) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-16-19 12:15PM  Novavax Begins Phase III Study on Influenza Vaccine Candidate Zacks
Oct-15-19 07:00AM  Novavax kicks off late-stage trial for new seasonal flu vaccine American City Business Journals
07:00AM  Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults GlobeNewswire
Oct-03-19 10:02AM  Have Insiders Been Selling Novavax, Inc. (NASDAQ:NVAX) Shares? Simply Wall St.
Sep-27-19 09:51AM  4 of the Best Stocks With Solid Earnings Acceleration Zacks -5.29%
Sep-19-19 07:00AM  Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire
Sep-17-19 12:14PM  Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock? Zacks -10.83%
Sep-10-19 07:14PM  Edited Transcript of NVAX earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
12:39PM  More bad news for Novavaxs RSV vaccine, this time in Europe American City Business Journals
Sep-06-19 07:00AM  Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-27-19 06:30AM  3 Top U.S. Stocks to Watch in September Motley Fool
Aug-26-19 10:25AM featured highlights include: Novavax, The Cooper Companies, Veeco Instruments and Maxar Technologies Zacks
Aug-23-19 08:35AM  4 Stocks That Boast Superb Earnings Acceleration Zacks -5.96%
Aug-21-19 09:39AM  Novavax, Inc. (NVAX) Shares March Higher, Can It Continue? Zacks
Aug-20-19 02:01PM  Need lab space? This Rockville research group is taking proposals. American City Business Journals -8.50%
Aug-19-19 06:00AM  Investors Who Bought Novavax (NASDAQ:NVAX) Shares Three Years Ago Are Now Down 94% Simply Wall St. -7.02%
Aug-18-19 07:37AM  3 Healthcare Stocks to Fight Off the Market Flu TipRanks
Aug-16-19 11:32AM  Why Novavax Stock Is Soaring Today Motley Fool +18.43%
Aug-15-19 09:30AM  4 Strong Buy Stocks to Follow Amid Recession Fears TipRanks +9.60%
Aug-14-19 01:03PM  Implied Volatility Surging for Novavax (NVAX) Stock Options Zacks +40.47%
01:00PM  Options Traders Take Chance on NVAX Stock After Big Analyst Call Schaeffer's Investment Research
Aug-13-19 02:19PM  New RSV vaccine data could boost Novavax as it searches for pathway to market American City Business Journals +6.97%
07:25AM  The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results Benzinga
Aug-12-19 07:00AM  New Data from Novavax Phase 3 Prepare Trial of ResVax Presented at 2019 IDSOG Annual Meeting GlobeNewswire
Aug-09-19 09:58AM  Novavax Inc (NVAX) Q2 2019 Earnings Call Transcript Motley Fool -5.03%
Aug-08-19 07:00AM  Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting GlobeNewswire -5.41%
Aug-07-19 08:25PM  Novavax (NVAX) Reports Q2 Loss, Misses Revenue Estimates Zacks
06:32PM  Novavax looks to next flu vaccine trial following sale of manufacturing business American City Business Journals
04:05PM  Novavax Reports Second Quarter 2019 Financial Results GlobeNewswire
11:27AM  Germantown biopharma regains compliance with Nasdaq American City Business Journals
Aug-06-19 07:22AM  The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering Benzinga +9.43%
Aug-05-19 04:05PM  Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu GlobeNewswire
Aug-01-19 09:25AM  Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019 GlobeNewswire +5.34%
Jul-31-19 04:30PM  Novavax and Catalent Announce Closing of Strategic Partnership GlobeNewswire
Jul-09-19 01:39PM  Germantown stem cell therapy company proposes $7M offering amid delisting threat American City Business Journals
Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein recombinant nanoparticle vaccine with aluminum phosphate as an adjuvant that is in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase II clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as allows immunization with much lower doses of antigen. The company also develops RSV F vaccine for older adults in Phase II clinical trial, and healthy children between two and six years of age in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus in Phase I clinical trial, as well as MERS coronavirus in animals; and combination respiratory vaccine to protect against influenza and RSV. The company has a clinical development agreement with Bill & Melinda Gates Foundation. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glenn Gregory MPresident, R&DJan 31Buy3.861,2504,8251,373Feb 04 05:11 PM
MCMANUS MICHAEL A JRDirectorNov 18Sale3.823,92915,0159,951Nov 20 04:17 PM
Herrmann John A IIISVP, General CounselSep 17Sale7.073,64325,7570Sep 18 04:14 PM
Glenn Gregory MPresident, R&DSep 13Sale6.189,62059,476123Sep 16 04:18 PM
Trizzino JohnSVP, CBO and CFOSep 11Sale5.725,57831,9114,800Sep 12 04:29 PM
Glenn Gregory MPresident, R&DMay 13Buy5.851,0005,85074,386May 13 05:19 PM
King Rachel K.DirectorMar 27Buy0.5344,00023,31122,000Mar 28 04:21 PM
King Rachel K.DirectorMar 27Buy0.5342,00022,25242,000Mar 28 04:21 PM